 |
|
Welcome to the ELRIG April Newsletter
Learn about the latest speakers confirmed for the Next Generation Sequencing Meeting this June, take part in the Innovation Zone hosted at Drug Discovery 2012, and don't miss out on the Companion Diagnostics event on 1st May - this is your last chance to pre-register for your complimentary delegate pass. |
|
NGS - Sequencing Technologies and Future Applications - 26th June
Join us for the 2nd ELRIG NGS meeting on 26th June.
Come and talk to the Industry Leaders from Illumina & Roche.
Keynote Speaker - Chris Detter, Los Alamos National Laboratory.
Chris has been the Group Leader of the Genomics Group at LANL. The Group primarily focuses on sequencing, finishing and analysis of viral, prokaryotic and eukaryotic genomes. He also chairs the organizing committee of Sequencing, Finishing, and Analysis in the Future. |
 | |
|
Speakers:
Welcome to the Home of Sequencing!
Michael Quail, Sanger Institute, Wellcome Trust.
Technological Options for Balancing the Speed, Cost and Breadth of Variant Discovery Through Sequencing.
David Buck, Oxford University
Overview of New Products for Oncology Research and the Future Path for New Sequencing Technologies from 454 Sequencing.
Dan Brekken, Roche, R & D.
Toby Ost, Pacific Biosciences.
Massimiliano Pagani, National Institute of Molecular Genetics.
Neil Ward, Illumina, R & D.
Delegates register free here.
Exhibitors book your stand here and take a look at the floorplan for Hinxton Hall, Cambridge.
Posters – send your abstracts to posters@elrig.org to secure your space. | |
|
The Innovation Zone at Drug Discovery 2012
It is a core part of ELRIG’s mission to encourage and assist new businesses and emerging technologies. One way we do this is to offer subsidised exhibition space at our Drug Discovery conference.
The ‘Innovation Zone’ is principally designed to give up-and-coming companies access to a major event in which they may not otherwise be able to participate.
We get a more diverse, more interesting show, and they get exposure to a large and very tuned-in audience!
Many ‘fledgling’ companies have passed through our i-zones on their way to becoming the established names of today. |
 | |
|
The Innovation Zone has proved to be a very popular feature at Drug Discovery, both with the vendors and the delegates.
If you are interested in participating this year, please contact us and we’ll send you an application: izone@elrig.org.
We are happy to consider research and non-commercial groups, and even those hoping to start a business! | |
|
1 WEEK TO GO - Last Chance to Pre-register for your Free Place
SomaLogic Announces the Launch of the SomaSciences Technology at the ELRIG ‘Companion Diagnostics’ Meeting
SomaLogic, Inc., announced the launch of SomaSciences in the United Kingdom, making SomaLogic’s breakthrough proteomic technology available to researchers across the country who seek to improve and accelerate their protein biomarker discovery efforts. |
 | |
|
The SomaSciences launch will take place at the ELRIG – ‘Companion Diagnostics’ Conference on May 1, 2012 at The Belfry, Oxford. Steven Williams, M.D., Ph.D., Chief Medical Officer of SomaLogic, will present the company’s technology in a talk entitled:
'Unlocking protein biomarker discovery for diagnostics and therapeutics; Rapid translation to diagnostic products'
“We are delighted that this is the first formal European availability of our technology,” said Dr. Williams. “We look forward to building on our current strong collaborations in the UK and establishing new ones that will create additional opportunities for building transformative health care products.”
Remember to Register for this meeting - it's free!
Submit your Poster Abstract
Book your Vendor Stand
This event is sponsored by Sagentia and Somalogic. | |
|
This issue is sponsored by Roche Applied Science:
If you do not wish to receive these emails in future, please let us know | |